Implementation and effectiveness of integrated @entity130 and addiction treatment for incarcerated XXXX .

@entity25515 @entity1 @entity1005 @entity734 @entity130
A controlled trial of @entity25515 ( @entity25515 ) and Male-Trauma Recovery Empowerment Model (M-TREM) examined implementation and effectiveness of integrated group therapy for comorbid @entity1005 ( @entity1005 ) and @entity734 ( @entity734 ) on @entity1005 and mental health symptoms plus self-esteem and efficacy for incarcerated @entity1 . The study sample (n=230) was male inmates 18 years or older who were primarily non-white, high school graduates or equivalents, had childhood @entity130 histories, committed violent crimes, had serious mental illnesses, and resided in a maximum security prison. Incarcerated @entity1 , who screened positive for @entity1005 and @entity734 , were assigned randomly (n=142) or by preference (n=88) to receive @entity25515 or M-TREM, with a waitlist group of (n=93). Manualized interventions were group-administered for 14 weeks. Primary outcomes were @entity1005 and other mental health symptoms. Secondary outcomes were self-esteem, coping, and self-efficacy. @entity734 outcomes cannot be measured in a correctional setting. Implementation feasibility was exhibited by the ability to recruit, screen, assign, and retain @entity1 . Effectiveness findings depended on sample, design, and method for analysis. Using a waitlist control group and no follow-up period, we found no aggregate effect of treatment on @entity1005 symptoms, although, when disaggregated, M-TREM was found to improve @entity1005 severity and @entity25515 improved general mental health symptoms and psychological functioning. Using intent-to-treat and completer analyses, no significant differences were found in the relative performance between @entity25515 and M-TREM on primary or secondary outcomes. When longitudinal data were maximized and modeled in ways that reflect the hierarchical nature of the data, we found that @entity25515 and M-TREM performed better than no treatment on @entity1005 severity and secondary outcomes, and that treatment benefits endured. Findings cautiously support implementing either @entity25515 or M-TREM to treat incarcerated @entity1 with co-morbid @entity1005 and addiction problems.
